Mark Olsen

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2025
Inhibition of Aspartate β-Hydroxylase Enhances Anti-Tumor Immunity.

Shweta Dilip Johari, Katerina Krausova, Barbora Zucha

|Mar 28, 2025
ASPH Is a Metastatic Factor and Therapeutic Target in Chondrosarcoma.

Xiaojuan Sun, Jesse Hart, Ross Taliano

|May 11, 2024
Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models.

Pritha Mukherjee, Xin Zhou, Susana Galli

|May 17, 2020
Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. <i>Cancers</i> <b>2020</b>, <i>12</i>, 971.

Roberto Benelli, Delfina Costa, Luca Mastracci

|Jun 17, 2015
Modern Approaches to Quality Assurance of Drug Formulations.

Josef Jampilek, Patrick J Crowley, Mark Olsen

Pageof 1

Frequent Collaborators

1 joint publications

Roberto Benelli

1 joint publications

Luca Mastracci

1 joint publications

Paola Barboro

1 joint publications

Alessandro Poggi